137 related articles for article (PubMed ID: 36826687)
1. Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.
Zhou J; Wu R; Williams C; Emberson J; Reith C; Keech A; Robson J; Wilkinson K; Armitage J; Gray A; Simes J; Baigent C; Mihaylova B
Pharmacoeconomics; 2023 May; 41(5):547-559. PubMed ID: 36826687
[TBL] [Abstract][Full Text] [Related]
2. Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.
Lui JNM; Williams C; Keng MJ; Hopewell JC; Sammons E; Chen F; Gray A; Bowman L; Landray SMJ; Mihaylova B;
J Am Heart Assoc; 2023 Oct; 12(19):e030766. PubMed ID: 37750555
[TBL] [Abstract][Full Text] [Related]
3. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
5. Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data.
Schlackow I; Simons C; Oke J; Feakins B; O'Callaghan CA; Hobbs FDR; Lasserson D; Stevens RJ; Perera R; Mihaylova B
PLoS Med; 2020 Dec; 17(12):e1003478. PubMed ID: 33326459
[TBL] [Abstract][Full Text] [Related]
6. Hospital costs associated with adverse events in people with diabetes in the UK.
Keng MJ; Leal J; Bowman L; Armitage J; Mihaylova B;
Diabetes Obes Metab; 2022 Nov; 24(11):2108-2117. PubMed ID: 35676793
[TBL] [Abstract][Full Text] [Related]
7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
8. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
Clarke P; Gray A; Legood R; Briggs A; Holman R
Diabet Med; 2003 Jun; 20(6):442-50. PubMed ID: 12786677
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany - results of a claims database study.
Sidelnikov E; Dornstauder E; Jacob C; Maas C; Pinto L; Leidl R; Ahrens I
J Med Econ; 2022; 25(1):1199-1206. PubMed ID: 36330899
[TBL] [Abstract][Full Text] [Related]
10. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
11. Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real-World Data From the UK.
Pineda-Moncusà M; El-Hussein L; Delmestri A; Cooper C; Moayyeri A; Libanati C; Toth E; Prieto-Alhambra D; Khalid S
J Bone Miner Res; 2022 Oct; 37(10):1986-1996. PubMed ID: 35818312
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.
Feary JR; Rodrigues LC; Smith CJ; Hubbard RB; Gibson JE
Thorax; 2010 Nov; 65(11):956-62. PubMed ID: 20871122
[TBL] [Abstract][Full Text] [Related]
13. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
[TBL] [Abstract][Full Text] [Related]
14. Strong and graded associations between level of asthma severity and all-cause hospital care use and costs in the UK.
Jacobs A; Wu R; Tomini F; De Simoni A; Mihaylova B
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38101812
[TBL] [Abstract][Full Text] [Related]
15. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific temporal trends in the incidence and prevalence of cardiovascular disease in young adults: a population-based study using UK primary care data.
Okoth K; Crowe F; Marshall T; Thomas GN; Nirantharakumar K; Adderley NJ
Eur J Prev Cardiol; 2022 Aug; 29(10):1387-1395. PubMed ID: 35139185
[TBL] [Abstract][Full Text] [Related]
18. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
[TBL] [Abstract][Full Text] [Related]
19. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies.
Zhang YB; Chen C; Pan XF; Guo J; Li Y; Franco OH; Liu G; Pan A
BMJ; 2021 Apr; 373():n604. PubMed ID: 33853828
[TBL] [Abstract][Full Text] [Related]
20. Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States-based retrospective claims database analysis.
Bangalore S; Shah R; Gao X; Pappadopulos E; Deshpande CG; Shelbaya A; Prieto R; Stephens J; Chambers R; Schepman P; McIntyre RS
J Med Econ; 2020 Mar; 23(3):262-270. PubMed ID: 31665949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
